Navigation Links
Glenmark Brings to the Notice of the Authorities Irregularities of the Clinical Investigator at its Jamnagar Site in Gujarat
Date:7/23/2009

MUMBAI, July 23 /PRNewswire-FirstCall/ --

- A Police Complaint has Been Lodged by Hospital Authorities Citing Fraudulent Activity by the Clinical Investigator Dr. A Bhattacharya Working at the GG Hospital and the MP Shah Medical College

- Glenmark Not Only Acts as the Whistle-Blower but Also Discontinues its Clinical Study at the Mentioned Site

After receiving approval from the Drug Controller General of India(DCGI) for a multi-centre Phase IIb clinical study for its lead COPD/asthma molecule, Oglemilast, Glenmark Pharmaceuticals Limited contracted Omnicare Clinical Research(Omnicare), a leading international CRO to conduct this Phase II asthma study on its behalf. Appropriate preclinical and clinical evaluations were completed prior to initiating this phase IIb asthma study. Being a multi-centre clinical study, one of the sites chosen was Guru Gobind Hospital, Jamnagar, Gujarat. Dr. A Bhattacharya, who was at that time working with the hospital was the clinical investigator for this mentioned site.

After Dr. Bhattacharya provided all necessary approvals and completed documentation, the site was initiated at the end of 2008. During monitoring activities immediately after initiation of the site, Omnicare suspected fraudulent activity. Without delay, Glenmark along with Omnicare carried out the appropriate for-cause audit and confirmed the fraud. This was immediately brought to the attention of the Chairman of the Ethics Committee at the concerned Hospital. Omnicare along with Glenmark acted swiftly and closed the site in line with normal regulatory requirements, to ensure the appropriate care/safety of the patients was protected. It is important to confirm that no patients have been put at risk, and no further patients have been or will be recruited in the clinical study at Jamnagar. Glenmark also immediately formally notified the DCGI of the situation at Dr Bhattacharya's site in early April 09 and in June provided the DCGI with an update of its actions and findings at the site.

Dr Bhattacharya has been accused of fraudulent behaviour by the Hospital Superintendent in Jamnagar, and as a result Dr Bhattacharya has now been suspended from the Baroda Medical College (where he was transferred from Jamnagar) while the police complete their investigations regarding the full extent of potential fraud by Dr. Bhattacharya in all clinical trials he had been involved in with other CROs and pharmaceutical companies.

Glenmark and Omnicare remain wholly committed to ensuring the highest quality and care in all their clinical trials in keeping with international regulatory and safety standards, and remain fully committed to taking strict action for early identification and prevention of such fraudulent activities in future. Glenmark has already decided that it will not consider any data received from this site pertaining to the study. The Phase IIb study continues to progress as per plan at other sites across the country. Being a leading company in the area of drug discovery and development, Glenmark Pharmaceuticals Ltd conducts all its clinical trials to the highest internationally recognised regulatory standards as defined by the International Conference on Harmonisation of Good Clinical Practice (ICH-GCP) and to local Indian regulations as recognised in Schedule Y of the Drugs and Cosmetics Act. In addition, Glenmark conducts all clinical trials in accordance with the internationally recognised ethical principals laid down in the Declaration of Helsinki, and the local Indian ICMR Ethical Guidelines.


'/>"/>
SOURCE Glenmark Pharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HealthPROSe Brings Creative, Strategic Thinking to Health Blogosphere
2. A Bundle of Joy Brings a Bundle of Questions - Life123.com Delivers the Answers!
3. As Fire Ants Continue to Proliferate, Hospital-Proven Burn Anesthetic Brings Instant Relief for Bites, Stings
4. Materials and Processes for Medical Devices Event Brings Clinicians, Engineers, Designers Together
5. USAID Brings White House Service Initiative to Baltimore
6. Opening Day of Fi Asia-China 2009 Brings the Food Ingredients Industry to Shanghai
7. Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village
8. White House Health Reform Stakeholder Discussion Brings Palliative Care to the Table
9. Best and Brightest Forum on Medical Innovation Brings Senator Arlen Specter, U.S. Representative Anna Eshoo, and Innovation Leaders Together in Washington, D.C., This Week
10. "Alliance between Europe Cosmetiques and Probiox brings new oxydative stress profiling technologies to North America"
11. St. Louis Firm Brings Medicare Risk Adjustment to iPhone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... the California Dental Association, today announced it has signed a letter of intent ... Corporation (DBC) and Northwest Dentists Insurance Company (NORDIC). , Started by dentists 36 ...
(Date:4/28/2016)... ... 28, 2016 , ... CastCoverz!, America’s #1 trusted brand for ... oldest waterproof cast protector . As the largest one-stop, orthopedic shop, CastCoverz! ... daily, night, weatherproof and waterproof covers for most orthopedic devices, including but not ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the organization’s most successful events, attracting medical professionals from around the globe who ... networking events. , Opening Ceremonies Sunday, April 17 included the introduction of the ...
(Date:4/28/2016)... ... April 28, 2016 , ... In many parts of the world, ... childhood mortality. This is particularly true in underdeveloped parts of Africa where clean sources ... New England’s campus in Tangier, Morocco, will examine this global health issue and consider ...
(Date:4/28/2016)... ... 28, 2016 , ... Cognizin® Citicoline is one of three ... the Healthy Ageing category, Cognizin® is being considered for this prestigious honor due ... include everything from antioxidants, lipids, proteins, and botanicals. NutraIngredients will choose a winner ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... , April 28, 2016  ValGenesis, Inc., ... Management Solutions (VLMS) today announced that a ... for sufferers of chronic kidney failure has ... manage their corporate validation process. The global ... software solution to manage their validation processes ...
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
Breaking Medicine Technology: